La FDA amplía la advertencia sobre unos productos oculares contaminados
MIÉRCOLES, 22 de febrero de 2023 (HealthDay News) — Deje de comprar o usar el ungüento para los ojos Artificial Eye Ointment de Delsam Pharma, advirtió el miércoles la Administración de Alimentos y Medicamentos (FDA) de EE. UU.El producto de venta li…
Learn MoreFDA Widens Warning for Contaminated Eye Products
WEDNESDAY, Feb. 22, 2023 (HealthDay News) — On Wednesday, the U.S. Food and Drug Administration warned consumers to stop buying or using the Delsam Pharma Artificial Eye Ointment. The over-the-counter product is made by the same company that makes ey…
Learn MoreFDA Widens Warning for Contaminated Eye Products
WEDNESDAY, Feb. 22, 2023 (HealthDay News) — Stop buying or using Delsam Pharma’s Artificial Eye Ointment, the U.S. Food and Drug Administration warned Wednesday.The over-the-counter product is made by the same company that makes eye drops that were r…
Learn More0.05 Percent Atropine Eye Drops Result in Lower Incidence of Myopia
TUESDAY, Feb. 14, 2023 (HealthDay News) — Nightly use of 0.05 percent atropine eye drops compared with placebo results in a significantly lower incidence of myopia and a lower percentage of patients with fast myopic shift at two years among children …
Learn MoreU.S. Adults Lack Knowledge About Age-Related Macular Degeneration
WEDNESDAY Feb. 8, 2023 (HealthDay News) — Most U.S. adults are unaware of warning signs of age-related macular degeneration (AMD) and treatment advances for the condition, according to survey results released by the American Society of Retina Special…
Learn MoreU.S. Adults Lack Knowledge About Age-Related Macular Degeneration
WEDNESDAY Feb. 8, 2023 (HealthDay News) — Most U.S. adults are unaware of warning signs of age-related macular degeneration (AMD) and treatment advances for the condition, according to survey results released by the American Society of Retina Special…
Learn MorePreventive Value of Aflibercept Questioned in NPDR Without CI-DME
TUESDAY, Feb. 7, 2023 (HealthDay News) — Treatment with aflibercept versus sham, initiating aflibercept only if vision-threatening complications develop, yields anatomic improvement but no improvement in visual acuity for patients with nonproliferati…
Learn MoreLos CDC advierten del riesgo de una peligrosa infección con las gotas para los ojos EzriCare
MIÉRCOLES, 1 de febrero de 2023 (HealthDay News) — Las autoridades de salud de EE. UU. están investigando si una marca específica de gotas para los ojos sin receta es responsable de una muerte y docenas de infecciones bacterianas en varios estados.No…
Learn MoreCDC Warns of Dangerous Infection Risk With EzriCare Eye Drops
WEDNESDAY, Feb. 1, 2023 (HealthDay News) — U.S. health officials are investigating whether a specific brand of over-the-counter eye drops are behind one death and dozens of bacterial infections in several states.The infections have not been traced to…
Learn MoreBlack, Hispanic Patients Have Worse Outcomes for Retinal Detachment
WEDNESDAY, Feb. 1, 2023 (HealthDay News) — Black and Hispanic patients treated surgically for retinal detachment have worse vision results than White patients, according to a study published online Jan. 4 in the Canadian Journal of Ophthalmology.Jia …
Learn More